Epidermal Growth Factor Receptor Mutation Frequency in Squamous Cell Carcinoma and Its Diagnostic Performance in Cytological Samples: A Molecular and Immunohistochemical Study

BACKGROUND: Epidermal growth factor receptor (EGFR) mutation is the most frequent mutation tested in lung cancer for targeted therapy in the era of personalized medicine. Knowledge about EGFR mutation is constantly expanding regarding its frequency, clinicopathological association, advancements in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Niraj, Singh, Shalini, Haloi, Dhanjit, Mishra, Shravan Kumar, Krishnani, Narendra, Nath, Alok, Neyaz, Zafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615915/
https://www.ncbi.nlm.nih.gov/pubmed/31312281
http://dx.doi.org/10.14740/wjon1204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615915/
https://www.ncbi.nlm.nih.gov/pubmed/31312281
http://dx.doi.org/10.14740/wjon1204

Ejemplares similares